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Antibodies to a synthetic peptide from the ‘amphipathic helix’ of the cc-chain of the nicotinic acetylcholine 
receptor (nAChR) bound both to detergent-solubilised and membrane-bound nAChR, indicating that this 
region, suggested as a component of the transmembrane ion channel in one model, is not buried in the mem- 
brane. Trypsinisation of membranes prior to affinity purification yielded preparations lacking the amphi- 
pathic helices of the c1- and P-chains and probably also of the y-and a-chains. Such material should allow 
direct testing, by reconstitution experiments, of the importance of these regions for channel activity. 
Acetylcholine receptor; Ion channel; Amphipathic helix; Synthetic peptide 
1. INTRODUCTION 
The nAChR from the electric ray, Torpedo, is a 
pentameric molecule, consisting of 4 different 
polypeptide chains (al, ,0, y, 6), whose amino acid 
sequences have been determined from cDNA data 
(review [l]). A popular model for the insertion of 
the chains in the membrane suggests that each sub- 
unit has 4 hydrophobic transmembrane regions 
(Ml-4) and that the intrinsic ion channel of the 
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nAChR is formed from a transmembrane amphi- 
pathic helix (M5) donated by each of the 5 chains 
[2]. In the case of the a-chain, this region cor- 
responds to residues 364-389. By trypsinisation of 
electric organ membranes before solubilisation and 
affinity purification, we have succeeded in obtain- 
ing preparations (tnAChR) lacking some or all of 
these suggested amphipathic heiices. Such material 
should be useful in testing, by reconstitution ex- 
periments, the ion channel role of these regions. 
2. MATERIALS AND METHODS 
2.1. Protein purification, radiolabelling, 
radioimmunoassay methods and 
electrophoresis techniques 
nAChR and tnAChR were purified from electric 
organs of T. marmorata as described [3]. nAChR 
and L~BTX were radiolabelled as in [4,5]. nAChR 
and tnAChR indirectly labelled with 12SI-~BTX 
were prepared as in [4]. Direct and competitive 
RIA were performed as described [6]. Electro- 
phoresis on 12.5% SDS-PAGE, transfer and blot- 
ting were as described in [3]. 
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2.2. Synthesis, purification and characterisation 
of peptides 
Peptides Pl and P3 (residues 151-169 and 
426-437, respectively, of the a-chain of T. califor- 
nica) were synthesised and characterised as 
described in [7,8]. 
Peptide P9 (residues 378-391 of the a-chain) was 
synthesised using Fmoc amino acids and the active 
ester solid-phase method [9]. Protected amino 
acids were purchased from Bachem (Switzerland); 
protecting groups were tertiary butyl ester (carbox- 
yl groups), tertiary butyl ether (hydroxyl groups) 
and benzyloxybarbonyl (N-terminal glycine and c- 
amino group of lysine). 
The peptide was cleaved from the resin with 
simultaneous deblocking of side-groups using 55% 
TFA in DMF in the presence of 1 ml of anisol/g of 
resin, evaporated to dryness, dissolved in 1 M 
acetic acid and lyophilised. After gel filtration on 
Sephadex G25 in 10% formic acid, the main peak 
was lyophilised then fractionated by ion-exchange 
chromatography on DEAE-Sephadex A50, equi- 
librated in 50 mM ammonium acetate, pH 5.0. 
After washing, a linear gradient of ammonium 
acetate (50 mM, pH 5.0-l M, pH 6.5) was ap- 
plied. The major peak was lyophilised and ana- 
lysed by reversed-phase HPLC, amino acid com- 
position and amino acid sequencing. (i) Reversed- 
phase HPLC showed essentially a single peak. (ii) 
Amino acid analysis after hydrolysis in 5.5 M 
hydrochloric acid at 120°C for 15 h under vacuum 
was performed by precolumn derivatisation with 
4-dimethylaminoazobenzene-4’-sulphonyl chloride 
[lo]. The results for 3 analyses, each of 3 hydro- 
lysates, were the following (expected values in 
brackets): Asp 0.94 (l), Glu 2.90 (3), Ser 1.08 (l), 
Gly 1.06 (l), Ala 1.00 (1), Val 0.97 (l), Met 0.88 
(l), Lys 1.95 (2), His 1.03 (l), Tyr 0.97 (1). (iii) N- 
terminal sequence analysis was performed using an 
Applied Biosystems 477A protein sequencer. Re- 
leased phenylthiohydantoin amino acid derivatives 
were identified by reversed-phase HPLC [ 111. The 
unique sequence GVKYIAEHMKDSEE was 
found. 
2.3. Preparation of antibodies 
Antisera to nAChR and tnAChR were raised in 
rabbits as in [12]. Antisera to P9 conjugated to 
KLH were raised as described for antisera to Pl 
and P3 [7,8]. Anti-P9 antibodies were purified by 
affinity chromatography on P9 conjugated to Af- 
figel 10 (Biorad). 
The production and characterisation of mAbs to 
the nAChR and its subunits have been described 
[13-161. 
2.4. ELISA assays 
nAChR or tnAChR (2.5 pg/ml in 0.1 M sodium 
bicarbonate, 50&well) was used to coat micro- 
titre plates overnight at 4°C. All further manipula- 
tions were at 22°C. The plates were washed with 
distilled water and blocked with PBS containing 
0.5% BSA, 5% Tween 20 (150,&well, 20 min). 
After 3 washes with PBS, 0.05% Tween 20 (buffer 
A), sequential incubations with suitable dilutions 
of primary antibody (50 PI/well, 1 h), second anti- 
body coupled to alkaline phosphatase (50 ,&well, 
1 h) and p-nitrophenylphosphate (1 mg/ml in 1 M 
diethanolamine, 0.5 mM magnesium chloride, pH 
9.8, lOO~l/well, 30 min) were performed. 3 
washes with buffer A (150~l/well) were carried 
out between steps. 25 ~1 of 2 M NaOH was added 
and the optical density at 405 nm measured. 
In blocking experiments, dilutions of primary 
antibody were chosen so as to be in the non- 
plateau region of the curve. The diluted antibody 
was then preincubated with an equal volume of test 
antigen at different concentrations for 1 h before 
addition to the plates. 
2.5. Precipitation of ‘251-~BTX trace-labelled 
Torpedo membranes 
Crude membranes (16.9 mg/ml, 0.9 nmol 
L~BTX binding sites/mg protein) from the electric 
organ of T. marmorata were prepared as in [3] and 
stored at -70°C. Before use, the closed vesicles 
were opened by 3 cycles of freeze-thaw and 2 
sonication steps; the effectiveness of this process 
was monitored by the increased sensitivity of the cy- 
chain to trypsin degradation [8]. An aliquot (30 ~1) 
was mixed with an equal volume of ‘2SI-~BTX 
(52 nM) and incubated for 30 min. 3 ml of PBS, 
1% BSA (buffer B) was added. 100 ,~l aliquots 
were incubated in duplicate with different volumes 
of affinity-purified anti-P9 antibodies or control 
rabbit IgG (approx. cont. of 0.25 mg/ml) for 1 h, 
before the addition of 50~1 of 10% (v/v) Staphy- 
/ococcus azueus Cowan strain I in buffer B. After 
30 min, 1 ml of buffer B was added and the tubes 
centrifuged at 840 x g, before 2 more washes in the 
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Fig. 1. SDS-gel electrophoresis and immunoblotting of 
nAChR and tnAChR and untreated and trypsinised 
membranes. (a) Coomassie blue stained gel (lanes): (1) 
molecular mass markers; (2) nAChR; (3) tnAChR. (b) 
Immunoblots of nAChR (lanes 1,3,5) and tnAChR 
(lanes 2,4,6) probed with anti-P1 antibodies (lanes 1,2), 
anti-P9 antibodies (lanes 3,4) and cyBTX (lanes 5,6). (c) 
Immunoblots of untreated (lanes 1,3) and trypsinised 
(lanes 2,4) membranes probed with anti-P1 (lanes 1,2) 
and anti-P9 (lanes 3,4) antibodies. 
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Fig.2. Reactivity of anti-P9 antibodies with nAChR. (a) 
ELISA assay using nAChR-coated plates. Affinity- 
purified anti-P9 antibodies from rabbit 1 (m, 0) or rab- 
bit 2 (o,O) were preincubated with buffer alone or dif- 
ferent concentrations of nAChR (M,o) or tnAChR 
(0 ,O), then tested for binding to nAChR-coated plates 
as described in section 2. Results are means + SE of 3 
tests. (b) RIA using ‘251-cr-BTX trace-labelled nAChR or 
tnAChR. Trace-labelled nAChR (m, q ,o,o) or tnAChR 
(*), 138 x lo3 cpm, was incubated with different 
volumes of anti-P9 antiserum (O,O,*) or affinity- 
purified antibodies ( n ,O) from rabbit 1 ( n , q , *) or rab- 
bit 2 (o,O,*) before precipitation with S. aureus. 
Results of blanks using normal rabbit serum or IgG have 
been subtracted. A polyclonal anti-nAChR antiserum 
precipitated 104 x lo3 cpm (nAChR) and 84 x lo3 cpm 
(tnAChR). (c) Precipitation of ?-aBTX trace-labelled 
Torpedo membranes. Crude membranes vesicles were 
opened by freeze-thaw and sonication steps then trace- 
labelled with “‘I-aBTX and reacted with affinity- 
purified anti-P9 antibodies as described in section 2. 
Results shown are means + SE of 2-5 determinations. 
Antibodies are from rabbit 1 (left) and rabbit 2 (right). 
Blanks using normal rabbit IgG have been subtracted. 
Polyclonal anti-nAChR antisera precipitated 
15 000 cpm. 
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same buffer. All incubations and all centrifugation 
steps were at 22°C and 4”C, respectively. Under 
these centrifugation conditions, precipitation of 
membranes in the absence of antibody was low. 
3. RESULTS 
3.1. Characterisation of anti-P9 antisera 
lmmunoblotting experiments using purified 
nAChR (fig.lb) or crude membranes (fig.lc) 
showed that affinity-purified anti-P9 antibodies 
reacted specifically with the a-chain of the 
nAChR. lmmunoblots of trypsinised membranes 
(fig.lc) showed that the anti-P9 antibodies bound 
to the same 10 kDa fragment previously described 
as containing the C-terminal peptide, P3 [8]. 
Anti-P9 antibodies bound to purified nAChR 
coated on microtitre plates; the binding was com- 
pletely abolished by competition with an excess of 
soluble nAChR (fig.2a). Anti-P9 antisera and 
affinity-purified antibodies bound both to RT 
complex (fig.2b) and open but intact membranes 
(fig.2c). 
3.2. Characterisation of nAChR prepared from 
trypsinised membranes (tnAChR) 
On SDS-PAGE, tnAChR and nAChR showed 
an overall similar pattern of protein bands. Their 
apparent molecular masses ranged from 36 to 
40 kDa for tnAChR compared with from 41 to 
68 kDa for nAChR (fig.la). The band at 36 kDa 
reacted with polyclonal antibodies to peptide Pl 
(a-chain residues 151-169), with mAbs to the MIR 
and with aBTX, as described [8]. In addition, a 
high molecular mass band was always present 
which reacted with these same reagents (fig.lb). 
The specific activity of tnAChR was higher than 
that of nAChR (8123 f 996, 6122 f 394 nmol tox- 
in binding/mg, respectively, mean and SE of 3 
determinations), in agreement with the decrease in 
apparent molecular masses of the different chains. 
In terms of antigenicity, tnAChR competed 
almost as effectively as nAChR with RT for poly- 
clonal antibodies to nAChR (not shown). The anti- 
nAChR antibody titres and onset of experimental 
myasthenia gravis in rabbits were similar in 
animals immunised with tnAChR or nAChR (not 
shown). 
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3.3. Absence of regions containing the 
‘amphipathic helix’ 
3.3.1. Lack of reaction of tnAChR with anti-P9 
antibodies 
As shown in fig.2b, anti-P9 antibodies did not 
bind to tnAChR labelled with “‘I-~uBTX, nor did 
tnAChR inhibit the binding of anti-P9 antibodies 
either to soluble RT (not shown) or to immobilised 
nAChR (fig.2a). 
On immunoblots, no binding of anti-P9 anti- 
bodies to tnAChR was observed (fig.lb). Similar 
results were obtained using polyclonal antibodies 
to the C-terminus of the a-chain [3]. 
Table I 
Reactivity of anti-nAChR mAbs with nAChR or 
tnAChR in ELISA tests 
mAb Epitope Direct ELISA Competitive 
nAChR tnAChR 
ELISA 
198 c, 37- 85 + + 100% 
149,187 ff339-347 + _ ND 
142 ~349-365 + + l-2% 
147 ~~360-379 + + l-2070 
8 @360-379 + _ ND 
153,155,164 (~371-386 + _ ND 
169 p335-375 + + 12.5% 
111,148 p370-405 + _ ND 
125 p430-445 + _ ND 
163,170 p460-470 + + 6% 
172 /3460-410 + _ ND 
97, 99,109 p ? + _ ND 
118,151 fi ? + _ ND 
11 P ? + + l-2070 
132,165,168 y ? + _ ND 
141,166 6315-415 + _ ND 
134,150 6 ? + _ ND 
mAbs, produced and characterised as in [13-161, were 
tested for direct binding to nAChR or tnAChR coated 
on microtitre plates. mAbs showing significant reaction 
with tnAChR (more than 12% of the binding of anti- 
MlR mAb 198) were retested in a competitive ELISA. 
mAbs were preincubated with different concentrations 
of nAChR or tnAChR, then free mAb was estimated us- 
ing nAChR-coated plates. The efficiency of tnAChR 
relative to nAChR in blocking the mAb was estimated 
from the amounts required for equivalent effects. (?) 
The epitope recognised by the mAb has not yet been 
localised. ND, not determined 
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3.3.2. Lack of reaction of tnAChR with mAbs to 
defined sites near the ‘helical’ regions 
mAbs whose binding sites have been character- 
ised [13-161 were tested by a direct ELISA for their 
ability to recognise nAChR or tnAChR. As shown 
in table 1, almost all mAbs tested, including 818 
reactive with residues 339-386 of the a-chain, 717 
reactive with residues 335-470 of the P-chain (N- 
and C-terminal to the ‘helical’ region) and 2/2 
reactive with residues 3 15-415 of the S-chain, 
showed little or no reactivity with tnAChR. Of the 
above antibodies, only 142, 147, 163, 169 and 170 
showed a significant reaction. Using a competitive 
ELISA in which tnAChR or nAChR were com- 
peted with immobilised nAChR for mAb, the in- 
hibitory activity of tnAChR relative to that of 
nAChR for these 5 antibodies was estimated as less 
than 2% for mAbs 142 and 147, 6% for 163 and 
170 and 12.5% for mAb 169. Of a further 11 mAbs 
(6 anti-D, 3 anti-y and 2 anti-d) whose binding sites 
are not characterised, only mAb 11 bound to 
tnAChR in solution or on microtitre plates. 
Wennogle et al. [ 171 have previously reported that 
trypsinisation of purified nAChR causes release of 
a 16 kDa fragment from the d-chain. Anderson et 
al. [ 181 showed that the& and B-chains of Torpedo 
nAChR, during in vitro synthesis in dog pancreatic 
rough ribosomal membranes, were cleaved by 
trypsin, yielding fragments of 7 and 12 kDa, 
respectively; in this case, the fragments were par- 
tially water-soluble at pH 10 and were degraded by 
higher trypsin concentrations, similar to those used 
in our experiments. Our results using mAbs 125 
and 169 (anti-,&) and 166 (anti-d) are in agreement 
with those of Anderson et al. [18]. 
4. DISCUSSION 
Our results using anti-peptide antibodies specific 
for the putative amphipathic helix of the a-chain 
clearly show that this region is absent from the 
tnAChR. The lack of reactivity of mAbs known to 
bind on either side of the corresponding segment 
of thefl-chain [ 141 strongly suggest that the amphi- 
pathic helix of this subunit is also absent (the low 
residual reactivity of a few mAbs presumably re- 
flects a low degree of cross-reactivity with a second 
site on the tnAChR). Owing to the lack of mAbs 
specific for this region of the y- and b-chains, we 
cannot completely rule out the possibility that the 
amphipathic helices of these subunits might still be 
present on the tnAChR. However, given the 
similarity in the structure of the 4 subunits, the 
availability of suitable trypsin-susceptible sites, the 
decrease in apparent molecular mass of all chains 
and the loss of the binding sites recognised by 7/7 
mAbs specific for the y- and S-chains, this would 
seem unlikely. 
Our experiments showing that anti-P9 anti- 
bodies bind both to membranes and to detergent- 
solubilised nAChR suggest that the amphipathic 
helix of the a-chain is not a transmembrane ion- 
channel, in agreement with the results of Ratnam 
et al. [14,16] which showed that mAbs binding 
near the amphipathic helices bind to the cytoplas- 
mic face of the membrane, and with the results of 
other groups which showed that the second 
putative hydrophobic transmembrane region (M2) 
of the B-chain is involved in ion-flux regulation 
[ 191 and is labelled by reactive channel blockers 
[20,21]. Reconstitution experiments using tnAChR 
should help to resolve this point. 
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